SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BioLase Technology, Inc. (BLTI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gurupup who wrote (143)8/25/1997 10:03:00 PM
From: crysball   of 706
 
Skipard how about an objective analysis of the balance sheet with a focus on cash and cash burn rate (past & projected).

Do you have a model which lays in a sales growth (by product) and the cash consumption associated with financing the associated inventory and receivables.

If so don't you very quickly arrive at the conclusion a secondary offering will be necessary to raise more cash given the burn rate...........one which will be dilutive?

When wil the company announce sales results of derma lasers?

It would seem the company can ill afford to financially support launching 2 new products (DERMA & DENTAL LSER) into production simultaneously , never the less the Laser Brush........Is the CFO in dreamland?

Is BLTI really well managed, if so why have they so seriously undereestimated the time & cost to get new products to market, and now are going to try to launch 3 virtually simultaneously.

If you are a major stockholder do you know what % is owned by mgmt, and by Institutions? Are you on the Bof D?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext